(Total Views: 368)
Posted On: 09/10/2019 1:24:19 PM
Post# of 148902
I just listened to conference , MS Gilead.
To me very disappointing , 30 minute long , but they talking like they are pay by word and not information ..
When Dr NP is talking he talk fast , they have so many things to talk about and never enough time.
Here is like they writing novel.
At about 18 minutes started to talk about HIV...
How they think PeEP is a future ,very happy with Truvada and soon will be Descovy..
After listening how much importance they putting in PrEP , properly imo , now I think that non-binding contract is with them... They must know what Leronlimab will do to their Truvada and Descovy in PrEP.........
About 21 minute they talk about capsid inhibitor....
very early study , SC injection , half life up to 24 weeks so injection possible every Q for PrEP , or with other daily medicine as a treatment.
So today I had impression they don't believe it will be good as mono treatment for HIV .
but then it may not be best as PrEP also...
But again very early study ...
At about 28 talking about NASH...
a difficult disease and major , major medical need.
They think it will take about 3 medicine to take care of it...
Hello Gilead , look that Leronlimab will do it on its own !!!!!!
OK after listening to this conference , Gilead is in desperate need of Leronlimab !!!!!!!
IMO as always.
To me very disappointing , 30 minute long , but they talking like they are pay by word and not information ..
When Dr NP is talking he talk fast , they have so many things to talk about and never enough time.
Here is like they writing novel.
At about 18 minutes started to talk about HIV...
How they think PeEP is a future ,very happy with Truvada and soon will be Descovy..
After listening how much importance they putting in PrEP , properly imo , now I think that non-binding contract is with them... They must know what Leronlimab will do to their Truvada and Descovy in PrEP.........
About 21 minute they talk about capsid inhibitor....
very early study , SC injection , half life up to 24 weeks so injection possible every Q for PrEP , or with other daily medicine as a treatment.
So today I had impression they don't believe it will be good as mono treatment for HIV .
but then it may not be best as PrEP also...
But again very early study ...
At about 28 talking about NASH...
a difficult disease and major , major medical need.
They think it will take about 3 medicine to take care of it...
Hello Gilead , look that Leronlimab will do it on its own !!!!!!
OK after listening to this conference , Gilead is in desperate need of Leronlimab !!!!!!!
IMO as always.
(3)
(0)Scroll down for more posts ▼
